Revolution Medicines (RVMD) Return on Sales (2019 - 2025)
Historic Return on Sales for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to 26.71%.
- Revolution Medicines' Return on Sales rose 7909400.0% to 26.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 84.09%, marking a year-over-year increase of 8483200.0%. This contributed to the annual value of 37.68% for FY2023, which is 306500.0% down from last year.
- Latest data reveals that Revolution Medicines reported Return on Sales of 26.71% as of Q3 2025, which was up 7909400.0% from 764.23% recorded in Q3 2024.
- Over the past 5 years, Revolution Medicines' Return on Sales peaked at 26.71% during Q3 2025, and registered a low of 764.23% during Q3 2024.
- Over the past 5 years, Revolution Medicines' median Return on Sales value was 11.19% (recorded in 2023), while the average stood at 119.46%.
- Its Return on Sales has fluctuated over the past 5 years, first crashed by -7515700bps in 2024, then surged by 7909400bps in 2025.
- Quarter analysis of 5 years shows Revolution Medicines' Return on Sales stood at 5.57% in 2021, then skyrocketed by 34bps to 3.69% in 2022, then tumbled by -5806bps to 217.7% in 2023, then crashed by -251bps to 764.23% in 2024, then soared by 103bps to 26.71% in 2025.
- Its Return on Sales was 26.71% in Q3 2025, compared to 764.23% in Q3 2024 and 699.74% in Q2 2024.